A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
Clinical trial NCT04698642 · COMPLETED
Trial details
- NCT number
- NCT04698642
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2020-11-12
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.